Tag Archives | F Aboagye-Nyame

Digital health technologies to support access to medicines and pharmaceutical services in the achievement of sustainable development goals

Konduri N, Aboagye-Nyame F, Mabirizi D, Hoppenworth K, Kibria MG, Doumbia S, Williams L, Mazibuko G.Digital health technologies to support access to medicines and pharmaceutical services in the achievement of sustainable development goals. Digit Health. 2018 May 3;4:2055207618771407. doi: 10.1177/2055207618771407.

Read the full article

Read full story · Comments are closed

Toward Building Resilient Pharmaceutical Systems: SIAPS Impact

A presentation by Francis Aboagye-Nyame, SIAPS Program Director, on March 1, 2018.

Read full story · Comments are closed

HIV and AIDS Commodity Management Tool for West Africa (OSPSIDA): Technical Guide

The West Africa Regional HIV Pharmaceutical Management Information Dashboard is developed and implemented for fifteen focus West African countries for better management of HIV and AIDS commodities. The goal of the Dashboard is to capture, track, aggregate, and disseminate information about antiretroviral drugs (ARVs), rapid test kits (RTKs), and other HIV and AIDS commodities to support evidence-based decision making in the West Africa subregion. The Dashboard will assist focus countries and subregional organizations in improving forecasting, supply planning, and procurement to support the continuous availability of ARVs, RTKs, and other HIV- and AIDS-related commodities.

Read full story · Comments are closed

HIV and AIDS Commodity Management Tool for West Africa (OSPSIDA): User Guide

The goal of the OSPSIDA Dashboard is to capture, track, aggregate, and disseminate information about antiretroviral drugs (ARVs), rapid test kits (RTKs), and other HIV and AIDS commodities to support evidence-based decision making in the West Africa subregion. The Dashboard offers regional partners a platform through which they may easily share information on funding flows and stock-out risks. The data available on this platform will be used to inform decision making and assist in identifying solutions to mitigate risks in the short-, medium-, and long-term. This User Guide assists users to make entries into the OSPSIDA Dashboard smoothly. The user guide has step-by-step guidance on how to access the dashboard, enter information, and generate reports.

Read full story · Comments are closed

Defining pharmaceutical systems strengthening: concepts to enable measurement

Hafner T, Walkowiak H, Lee D, Aboagye-Nyame F. Defining pharmaceutical systems strengthening: Concepts to enable measurement. Health Policy and Planning Advance Access. 2016; 1-13.

Read the full article

 

Read full story · Comments are closed

Information Systems and Coordination for Managing HIV and AIDS Related Commodities

The West and Central African regions have a low HIV prevalence. Because of the low number of patients on ART and limited technical and financial support, these regions have experienced frequent stock-outs of ARVs posing a serious risk to patients on ART and increasing the risk of HIV drug resistance in the region. As a key step in addressing this challenge, the West Africa Regional Health Office of the US Agency for International Development is providing support through the Systems for Improved Access to Pharmaceuticals and Services (SIAPS) Program to address the recurring pharmaceutical supply management issues by supporting the regional coordination mechanism and the development and implementation of an early warning system (EWS) for antiretrovirals (ARVs) and HIV and AIDS related commodities.

As part of project startup, SIAPS conducted a situational analysis in Burkina Faso, Cameroon, Guinea, Niger, and Togo to gain an understanding of the current capacity for HIV and AIDS commodities management and supply. Also analyzed was the readiness of the HIV and AIDS commodities information management systems to provide the information necessary for routine monitoring of HIV and AIDS product availability in the region.

Read full story · Comments are closed

Pharmaceutical System Strengthening Interventions to Improve Access to Antiretroviral Therapy

The world’s response to the AIDS pandemic of dramatically increased financial assistance to provide affordable medicines for HIV and AIDS did not automatically lead to access to antiretrovirals (ARVs). The effectiveness of these multimillion dollar initiatives was recognized to be limited by the capacity of the health care and pharmaceutical supply systems to deliver these lifesaving medicines. Constraints to improving access to ARVs included inadequate capacity in clinics and hospitals that provide antiretroviral therapy (ART); inadequate pharmaceutical planning and information systems; and an inefficient supply chain.

A holistic approach to access looks beyond product availability and price to include other essential components, such as the availability of quality pharmaceutical services and the ability of the patient to benefit from both products and services that support the safe, effective, and appropriate use of the medicines.

Countries have stepped up to meet this challenge. This paper illustrates pharmaceutical systems’ strengthening interventions and their impact on improving access to ARVs and related services as well as continuing challenges and some recommendations.

Read full story · Comments are closed